A 2015 study from the Journal of Weight problems & Metabolic Syndrome addresses prevalent adverse situations and serious Unwanted side effects of anti-being overweight medications, which include phentermine/topiramate that will need monitoring, which include metabolic acidosis, urolithiasis, acute angle closure glaucoma, and teratogenic outcomes (